Trevi Therapeutics Inc (TRVI) — Financial Flexibility Index
Trevi Therapeutics Inc (TRVI) has a Financial Flexibility Index of -1.14x as of September 2025. Free cash flow of $-10.87 Million (operating CF $-10.88 Million minus capex $12.00K) represents -1% of total liabilities ($9.57 Million). Also explore net asset growth rate of Trevi Therapeutics Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Trevi Therapeutics Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Trevi Therapeutics Inc across 9 annual periods. Check asset allocation strategy of Trevi Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Trevi Therapeutics Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Trevi Therapeutics Inc. For the full company profile including market capitalisation, see Trevi Therapeutics Inc (TRVI) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.40x | $-38.22 Million | $-38.26 Million | $11.26 Million | ▲ +26.3% |
| 2023 | -4.61x | $-31.57 Million | $-31.71 Million | $6.86 Million | ▼ -155.7% |
| 2022 | -1.80x | $-28.02 Million | $-28.18 Million | $15.56 Million | ▼ -33.9% |
| 2021 | -1.35x | $-28.79 Million | $-28.95 Million | $21.40 Million | ▲ +7.8% |
| 2020 | -1.46x | $-28.97 Million | $-29.00 Million | $19.85 Million | ▲ +65.5% |
| 2019 | -4.23x | $-23.08 Million | $-23.09 Million | $5.46 Million | ▲ +25.8% |
| 2018 | -5.70x | $-18.13 Million | $-18.29 Million | $3.18 Million | ▼ -433.2% |
| 2017 | -1.07x | $-7.96 Million | $-7.97 Million | $7.45 Million | ▼ -146.8% |
| 2016 | -0.43x | $-11.18 Million | $-11.19 Million | $25.82 Million | — |